Developing a single-session strategy for the implementation of take-home naloxone by community pharmacists using COM-B and design-thinking.
COM-B
design-thinking
implementation science
naloxone
opioid overdose
pharmacy
theoretical models
Journal
Frontiers in health services
ISSN: 2813-0146
Titre abrégé: Front Health Serv
Pays: Switzerland
ID NLM: 9918334887706676
Informations de publication
Date de publication:
2023
2023
Historique:
received:
23
05
2023
accepted:
14
07
2023
medline:
21
8
2023
pubmed:
21
8
2023
entrez:
21
8
2023
Statut:
epublish
Résumé
Despite the overwhelming evidence of its effectiveness, there is poor implementation of take-home naloxone by pharmacists. Barriers have been explored and mapped to the capability, opportunity, motivation-behaviour (COM-B) model of behaviour change, yet no theoretically informed implementation strategies that target known barriers have been developed. Single-session implementation strategies have been proposed as a simple, scalable way to target multiple barriers. Qualitative participatory methods, incorporating design-thinking principles, were used to develop the key messages of a single-session implementation strategy. The key messages were drafted against COM-B mapped implementation barriers identified in the literature. A participatory workshop involving a pre-mortem exercise and incorporating design-thinking principles were used to refine the messages and generate methods for dissemination. Messages were mapped to interview questions to naturally illicit stories and delivered via storytelling from a pharmacist, a general practitioner, and a person with lived experience of using naloxone. A 3 minute 40 second video and a two-page printable infographic were developed and hosted on a website, with links to additional downloadable resources as a single-session implementation strategy. Email was the preferred method for receiving simple professional development communications, with social media also widely accessed. Implementation science, behavioural change theory, and participatory design methods are a complementary combination to develop implementation strategies. Some pharmacists questioned the participatory design approach to developing an implementation strategy, as it was outside of their comfort zone. However, the participatory process involving end-users resulted in unique ideas that are unlikely to have been generated using more traditional consultative approaches. The delivery as a single-session implementation strategy allows for widespread dissemination and delivery at scale.
Sections du résumé
Background
UNASSIGNED
Despite the overwhelming evidence of its effectiveness, there is poor implementation of take-home naloxone by pharmacists. Barriers have been explored and mapped to the capability, opportunity, motivation-behaviour (COM-B) model of behaviour change, yet no theoretically informed implementation strategies that target known barriers have been developed. Single-session implementation strategies have been proposed as a simple, scalable way to target multiple barriers.
Methods
UNASSIGNED
Qualitative participatory methods, incorporating design-thinking principles, were used to develop the key messages of a single-session implementation strategy. The key messages were drafted against COM-B mapped implementation barriers identified in the literature. A participatory workshop involving a pre-mortem exercise and incorporating design-thinking principles were used to refine the messages and generate methods for dissemination. Messages were mapped to interview questions to naturally illicit stories and delivered via storytelling from a pharmacist, a general practitioner, and a person with lived experience of using naloxone.
Results
UNASSIGNED
A 3 minute 40 second video and a two-page printable infographic were developed and hosted on a website, with links to additional downloadable resources as a single-session implementation strategy. Email was the preferred method for receiving simple professional development communications, with social media also widely accessed.
Discussion
UNASSIGNED
Implementation science, behavioural change theory, and participatory design methods are a complementary combination to develop implementation strategies. Some pharmacists questioned the participatory design approach to developing an implementation strategy, as it was outside of their comfort zone. However, the participatory process involving end-users resulted in unique ideas that are unlikely to have been generated using more traditional consultative approaches. The delivery as a single-session implementation strategy allows for widespread dissemination and delivery at scale.
Identifiants
pubmed: 37600924
doi: 10.3389/frhs.2023.1227360
pmc: PMC10434522
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1227360Informations de copyright
© 2023 Moullin, Ely, Uren, Staniland, Nielsen and Lenton.
Déclaration de conflit d'intérêts
The author JM declared that she was an editorial board member of Frontiers at the time of submission. This had no impact on the peer review process and the final decision. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Harm Reduct J. 2022 Feb 23;19(1):18
pubmed: 35197057
J Clin Child Adolesc Psychol. 2020 Mar-Apr;49(2):264-278
pubmed: 31799863
Res Social Adm Pharm. 2023 Feb;19(2):243-265
pubmed: 36156267
J Am Pharm Assoc (2003). 2020 Jan - Feb;60(1):81-86
pubmed: 31669417
Front Health Serv. 2022 Sep 23;2:997406
pubmed: 36925822
Drug Alcohol Depend. 2017 Oct 1;179:291-298
pubmed: 28826104
BMC Public Health. 2021 Mar 26;21(1):597
pubmed: 33771150
Transl Behav Med. 2021 May 25;11(5):1115-1121
pubmed: 32986098
Res Social Adm Pharm. 2019 Aug;15(8):1014-1020
pubmed: 30926251
J Am Pharm Assoc (2003). 2020 Jan - Feb;60(1):178-194
pubmed: 31371179
Int Q Community Health Educ. 2020 Oct;41(1):101-114
pubmed: 31973626
Subst Abus. 2019;40(4):476-483
pubmed: 31418645
Addiction. 2016 Dec;111(12):2177-2186
pubmed: 27367125
Med J Aust. 2020 Apr;212(7):314-320
pubmed: 32124984
Pharmacy (Basel). 2021 Feb 02;9(1):
pubmed: 33540676
Health (London). 2022 Mar;26(2):139-161
pubmed: 32529843
Implement Sci. 2022 Aug 13;17(1):55
pubmed: 35964095
Res Social Adm Pharm. 2019 Dec;15(12):1415-1418
pubmed: 30007530
Int J Drug Policy. 2021 Apr;90:103061
pubmed: 33321285
Med J Aust. 2016 Mar 7;204(4):146-7
pubmed: 26937664